ΠΑΡΚΙΝΣΟΝ
Παραπομπές:
1. Yadav SK, Ir R, Jeewon R, Doble M, Hyde KD, Kaliappan I, Jeyaraman R, Reddi RN, Krishnan J, Li M, Durairajan SSK. A Mechanistic Review on Medicinal Mushrooms-Derived Bioactive Compounds: Potential Mycotherapy Candidates for Alleviating Neurological Disorders. Planta Med. 2020 Nov;86(16):1161-1175. doi: 10.1055/a-1177-4834. Epub 2020 Jul 14. PMID: 32663897.
https://pubmed.ncbi.nlm.nih.gov/32663897/
2. Quan Y, Ma A, Yang B. Preventive and Therapeutic Effect of Ganoderma (Lingzhi) on Brain Injury. Adv Exp Med Biol. 2019;1182:159-180. doi: 10.1007/978-981-32-9421-9_6. PMID: 31777018.
https://pubmed.ncbi.nlm.nih.gov/31777018/
3. Chen LW, Wang YQ, Wei LC, Shi M, Chan YS. Chinese herbs and herbal extracts for neuroprotection of dopaminergic neurons and potential therapeutic treatment of Parkinson's disease. CNS Neurol Disord Drug Targets. 2007 Aug;6(4):273-81. doi: 10.2174/187152707781387288. PMID: 17691984.
https://pubmed.ncbi.nlm.nih.gov/17691984/
4. Vo, T. S. & Vo, Tran Thi Bich Chau & Vo, Tran Thi Thu Ngoc. (2021). Available Chemical Constituents and Activities of Ganoderma Lucidum (Lingzhi or Red Reishi) Utilizing in Disease Treatment: A mini review. Journal of Research in Clinical Medicine. 9. 10.34172/jrcm.2021.032.
https://jrcm.tbzmed.ac.ir/Article/jrcm-31996
5. Ren ZL, Wang CD, Wang T, et al. Ganoderma lucidum extract ameliorates MPTP-induced parkinsonism and protects dopaminergic neurons from oxidative stress via regulating mitochondrial function, autophagy, and apoptosis. Acta Pharmacologica Sinica. 2019 Apr;40(4):441-450. DOI: 10.1038/s41401-018-0077-8. PMID: 29991712; PMCID: PMC6461997.
https://europepmc.org/article/MED/29991712
6. Poewe W, Seppi K, Tanner CM, et al. Parkinson disease. Nature reviews. Disease Primers. 2017 Mar;3:17013. DOI: 10.1038/nrdp.2017.13. PMID: 28332488.
http://europepmc.org/article/MED/28332488
7. Simon DK, Tanner CM, Brundin P. Parkinson Disease Epidemiology, Pathology, Genetics, and Pathophysiology. Clinics in Geriatric Medicine. 2020 Feb;36(1):1-12. DOI: 10.1016/j.cger.2019.08.002. PMID: 31733690; PMCID: PMC6905381.
https://europepmc.org/article/PMC/6905381
8. Kuypers KPC. Self-Medication with <i>Ganoderma lucidum</i> ("Reishi") to Combat Parkinson's Disease Symptoms: A Single Case Study. Journal of Medicinal Food. 2021 Jul;24(7):766-773. DOI: 10.1089/jmf.2020.0137. PMID: 33170078; PMCID: PMC8311956.
https://europepmc.org/article/MED/33170078
9. Qin Z, Zhang L, Sun F, Liu H, Fang X, Chan P; Chinese Parkinson Study Group. Depressive symptoms impacting on health-related quality of life in early Parkinson's disease: results from Chinese L-dopa exposed cohort. Clin Neurol Neurosurg. 2009 Nov;111(9):733-7. doi: 10.1016/j.clineuro.2009.07.001. Epub 2009 Aug 8. PMID: 19665835.
https://pubmed.ncbi.nlm.nih.gov/19665835/
10. Hemmerle AM, Herman JP, Seroogy KB. Stress, depression and Parkinson's disease. Experimental Neurology. 2012 Jan;233(1):79-86. DOI: 10.1016/j.expneurol.2011.09.035. PMID: 22001159; PMCID: PMC3268878.
https://europepmc.org/article/PMC/3268878
11. Phan CW, David P, Naidu M, Wong KH, Sabaratnam V. Therapeutic potential of culinary-medicinal mushrooms for the management of neurodegenerative diseases: diversity, metabolite, and mechanism. Crit Rev Biotechnol. 2015;35(3):355-68. doi: 10.3109/07388551.2014.887649. PMID: 24654802.
https://pubmed.ncbi.nlm.nih.gov/24654802/
12. Guo SS, Cui XL, Rausch WD. Ganoderma Lucidum polysaccharides protect against MPP(+) and rotenone-induced apoptosis in primary dopaminergic cell cultures through inhibiting oxidative stress. American Journal of Neurodegenerative Disease. 2016 ;5(2):131-144. PMID: 27335703; PMCID: PMC4913221.
https://europepmc.org/article/MED/27335703
13. Zhang R, Xu S, Cai Y, et al. Ganoderma lucidum Protects Dopaminergic Neuron Degeneration through Inhibition of Microglial Activation. Evidence-based Complementary and Alternative Medicine : Ecam. 2011 ;2011:156810. DOI: 10.1093/ecam/nep075. PMID: 19617199; PMCID: PMC3136196.
https://europepmc.org/article/MED/19617199
14. Gill BS, Kumar S, Navgeet. Ganoderic acid targeting nuclear factor erythroid 2-related factor 2 in lung cancer. Tumour Biol. 2017 Mar;39(3):1010428317695530. doi: 10.1177/1010428317695530. PMID: 28349780.
https://pubmed.ncbi.nlm.nih.gov/28349780/
15. Ganji F, Barari A, Abdi A. Effects of Ganoderma Extraction and Eight-Week Endurance Exercises on Plasma Values Neurotrophic Factors Based on Brain and Nerve Growth in Men with Parkinson's. RJMS 2021; 27 (12) :120-130
https://rjms.iums.ac.ir/article-1-6505-en.html
16. Zhang R, Xu S, Cai Y, et al. Ganoderma lucidum Protects Dopaminergic Neuron Degeneration through Inhibition of Microglial Activation. Evidence-based Complementary and Alternative Medicine : Ecam. 2011 ;2011:156810. DOI: 10.1093/ecam/nep075. PMID: 19617199; PMCID: PMC3136196.
https://europepmc.org/article/MED/19617199
17. Zhang R, Xu S, Cai Y, et al. Ganoderma lucidum Protects Dopaminergic Neuron Degeneration through Inhibition of Microglial Activation. Evidence-based Complementary and Alternative Medicine : Ecam. 2011 ;2011:156810. DOI: 10.1093/ecam/nep075. PMID: 19617199; PMCID: PMC3136196.
https://pubmed.ncbi.nlm.nih.gov/21170502/
18. McFarthing K, Rafaloff G, Baptista M, et al. Parkinson's Disease Drug Therapies in the Clinical Trial Pipeline: 2022 Update. Journal of Parkinson's Disease. 2022 ;12(4):1073-1082. DOI: 10.3233/jpd-229002. PMID: 35527571; PMCID: PMC9198738.
https://europepmc.org/article/pmc/pmc9198738
19. Effects of Lingzhi on Disease Progression in Patients With Untreated Early Parkinson's Disease, ClinicalTrials.gov.
https://clinicaltrials.gov/ct2/show/record/NCT03594656?view=record
1. Yadav SK, Ir R, Jeewon R, Doble M, Hyde KD, Kaliappan I, Jeyaraman R, Reddi RN, Krishnan J, Li M, Durairajan SSK. A Mechanistic Review on Medicinal Mushrooms-Derived Bioactive Compounds: Potential Mycotherapy Candidates for Alleviating Neurological Disorders. Planta Med. 2020 Nov;86(16):1161-1175. doi: 10.1055/a-1177-4834. Epub 2020 Jul 14. PMID: 32663897.
https://pubmed.ncbi.nlm.nih.gov/32663897/
2. Quan Y, Ma A, Yang B. Preventive and Therapeutic Effect of Ganoderma (Lingzhi) on Brain Injury. Adv Exp Med Biol. 2019;1182:159-180. doi: 10.1007/978-981-32-9421-9_6. PMID: 31777018.
https://pubmed.ncbi.nlm.nih.gov/31777018/
3. Chen LW, Wang YQ, Wei LC, Shi M, Chan YS. Chinese herbs and herbal extracts for neuroprotection of dopaminergic neurons and potential therapeutic treatment of Parkinson's disease. CNS Neurol Disord Drug Targets. 2007 Aug;6(4):273-81. doi: 10.2174/187152707781387288. PMID: 17691984.
https://pubmed.ncbi.nlm.nih.gov/17691984/
4. Vo, T. S. & Vo, Tran Thi Bich Chau & Vo, Tran Thi Thu Ngoc. (2021). Available Chemical Constituents and Activities of Ganoderma Lucidum (Lingzhi or Red Reishi) Utilizing in Disease Treatment: A mini review. Journal of Research in Clinical Medicine. 9. 10.34172/jrcm.2021.032.
https://jrcm.tbzmed.ac.ir/Article/jrcm-31996
5. Ren ZL, Wang CD, Wang T, et al. Ganoderma lucidum extract ameliorates MPTP-induced parkinsonism and protects dopaminergic neurons from oxidative stress via regulating mitochondrial function, autophagy, and apoptosis. Acta Pharmacologica Sinica. 2019 Apr;40(4):441-450. DOI: 10.1038/s41401-018-0077-8. PMID: 29991712; PMCID: PMC6461997.
https://europepmc.org/article/MED/29991712
6. Poewe W, Seppi K, Tanner CM, et al. Parkinson disease. Nature reviews. Disease Primers. 2017 Mar;3:17013. DOI: 10.1038/nrdp.2017.13. PMID: 28332488.
http://europepmc.org/article/MED/28332488
7. Simon DK, Tanner CM, Brundin P. Parkinson Disease Epidemiology, Pathology, Genetics, and Pathophysiology. Clinics in Geriatric Medicine. 2020 Feb;36(1):1-12. DOI: 10.1016/j.cger.2019.08.002. PMID: 31733690; PMCID: PMC6905381.
https://europepmc.org/article/PMC/6905381
8. Kuypers KPC. Self-Medication with <i>Ganoderma lucidum</i> ("Reishi") to Combat Parkinson's Disease Symptoms: A Single Case Study. Journal of Medicinal Food. 2021 Jul;24(7):766-773. DOI: 10.1089/jmf.2020.0137. PMID: 33170078; PMCID: PMC8311956.
https://europepmc.org/article/MED/33170078
9. Qin Z, Zhang L, Sun F, Liu H, Fang X, Chan P; Chinese Parkinson Study Group. Depressive symptoms impacting on health-related quality of life in early Parkinson's disease: results from Chinese L-dopa exposed cohort. Clin Neurol Neurosurg. 2009 Nov;111(9):733-7. doi: 10.1016/j.clineuro.2009.07.001. Epub 2009 Aug 8. PMID: 19665835.
https://pubmed.ncbi.nlm.nih.gov/19665835/
10. Hemmerle AM, Herman JP, Seroogy KB. Stress, depression and Parkinson's disease. Experimental Neurology. 2012 Jan;233(1):79-86. DOI: 10.1016/j.expneurol.2011.09.035. PMID: 22001159; PMCID: PMC3268878.
https://europepmc.org/article/PMC/3268878
11. Phan CW, David P, Naidu M, Wong KH, Sabaratnam V. Therapeutic potential of culinary-medicinal mushrooms for the management of neurodegenerative diseases: diversity, metabolite, and mechanism. Crit Rev Biotechnol. 2015;35(3):355-68. doi: 10.3109/07388551.2014.887649. PMID: 24654802.
https://pubmed.ncbi.nlm.nih.gov/24654802/
12. Guo SS, Cui XL, Rausch WD. Ganoderma Lucidum polysaccharides protect against MPP(+) and rotenone-induced apoptosis in primary dopaminergic cell cultures through inhibiting oxidative stress. American Journal of Neurodegenerative Disease. 2016 ;5(2):131-144. PMID: 27335703; PMCID: PMC4913221.
https://europepmc.org/article/MED/27335703
13. Zhang R, Xu S, Cai Y, et al. Ganoderma lucidum Protects Dopaminergic Neuron Degeneration through Inhibition of Microglial Activation. Evidence-based Complementary and Alternative Medicine : Ecam. 2011 ;2011:156810. DOI: 10.1093/ecam/nep075. PMID: 19617199; PMCID: PMC3136196.
https://europepmc.org/article/MED/19617199
14. Gill BS, Kumar S, Navgeet. Ganoderic acid targeting nuclear factor erythroid 2-related factor 2 in lung cancer. Tumour Biol. 2017 Mar;39(3):1010428317695530. doi: 10.1177/1010428317695530. PMID: 28349780.
https://pubmed.ncbi.nlm.nih.gov/28349780/
15. Ganji F, Barari A, Abdi A. Effects of Ganoderma Extraction and Eight-Week Endurance Exercises on Plasma Values Neurotrophic Factors Based on Brain and Nerve Growth in Men with Parkinson's. RJMS 2021; 27 (12) :120-130
https://rjms.iums.ac.ir/article-1-6505-en.html
16. Zhang R, Xu S, Cai Y, et al. Ganoderma lucidum Protects Dopaminergic Neuron Degeneration through Inhibition of Microglial Activation. Evidence-based Complementary and Alternative Medicine : Ecam. 2011 ;2011:156810. DOI: 10.1093/ecam/nep075. PMID: 19617199; PMCID: PMC3136196.
https://europepmc.org/article/MED/19617199
17. Zhang R, Xu S, Cai Y, et al. Ganoderma lucidum Protects Dopaminergic Neuron Degeneration through Inhibition of Microglial Activation. Evidence-based Complementary and Alternative Medicine : Ecam. 2011 ;2011:156810. DOI: 10.1093/ecam/nep075. PMID: 19617199; PMCID: PMC3136196.
https://pubmed.ncbi.nlm.nih.gov/21170502/
18. McFarthing K, Rafaloff G, Baptista M, et al. Parkinson's Disease Drug Therapies in the Clinical Trial Pipeline: 2022 Update. Journal of Parkinson's Disease. 2022 ;12(4):1073-1082. DOI: 10.3233/jpd-229002. PMID: 35527571; PMCID: PMC9198738.
https://europepmc.org/article/pmc/pmc9198738
19. Effects of Lingzhi on Disease Progression in Patients With Untreated Early Parkinson's Disease, ClinicalTrials.gov.
https://clinicaltrials.gov/ct2/show/record/NCT03594656?view=record
